Literature DB >> 18307223

Closure of the femoral artery after cardiac catheterization: a comparison of Angio-Seal, StarClose, and manual compression.

J H H Deuling1, R P Vermeulen, R A Anthonio, A F M van den Heuvel, T Jaarsma, G Jessurun, B J G L de Smet, E S Tan, F Zijlstra.   

Abstract

OBJECTIVES: To compare Angio-Seal (AS) and StarClose (SC) and manual compression (MC) on efficacy of hemostasis, complication rate, safety of early mobilization, and patient comfort.
BACKGROUND: Closure of the femoral artery after cardiac catheterization can be obtained through different methods. Today, physicians can choose from a number of different devices to achieve arterial closure.
METHODS: In a prospective trial 450 patients were randomized to AS, SC, or MC. Patients were mobilized 1 to 2 hr after device placement, and 6 hr after MC. Data were collected during hospital admission and by telephone at one month after hospital discharge.
RESULTS: Devices were used in 138/150 allocated to AS and 124/150 allocated to SC patients (92% vs. 83%, P = 0.015) Patients with MC experienced more pain during sheath removal than patients receiving a device, and rated their period of bed rest as less comfortable. Oozing and need for pressure bandage at the puncture site were observed in 37 AS patients and 57 SC patients (25% vs. 38%, P = 0.002). Hematoma occurred in 15 AS patients, in 17 SC patients, and in 14 MC patients (11 vs. 14 vs. 9%, ns).
CONCLUSION: There is no difference in safety between the three methods of arterial closure. SC was more often not used or successfully deployed. SC patients more often had continuing oozing. On patient comfort, closure devices performed better than MC. Early ambulation in patients with a closure device is safe. AS is the preferred method of arterial closure after cardiac catheterization. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18307223     DOI: 10.1002/ccd.21429

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  6 in total

1.  Comparison of Exo-Seal(®) and Angio-Seal (®) for arterial puncture site closure: A randomized, multicenter, single-blind trial.

Authors:  Johannes Ketterle; Harald Rittger; Inga Helmig; Lutz Klinghammer; Stefan Zimmermann; Wolfgang Hohenforst-Schmidt; Johannes Brachmann; Holger Nef; Stephan Achenbach; Christian Schlundt
Journal:  Herz       Date:  2015-06-13       Impact factor: 1.443

2.  Incidence of delayed angiographic femoral artery complications using the EXOSEAL vascular closure device.

Authors:  Ramesh Grandhi; Xiaoran Zhang; David Panczykowski; Phillip Choi; Christopher T Hunnicutt; Ashutosh P Jadhav; Andrew F Ducruet; Tudor Jovin; Brian Jankowitz
Journal:  Interv Neuroradiol       Date:  2015-05-26       Impact factor: 1.610

Review 3.  Network Meta-analysis of Randomized Trials on the Safety of Vascular Closure Devices for Femoral Arterial Puncture Site Haemostasis.

Authors:  Jun Jiang; Junjie Zou; Hao Ma; Yuanyong Jiao; Hongyu Yang; Xiwei Zhang; Yi Miao
Journal:  Sci Rep       Date:  2015-09-08       Impact factor: 4.379

Review 4.  Interventional Radiology in the Management of Visceral Artery Pseudoaneurysms: A Review of Techniques and Embolic Materials.

Authors:  Kumble Seetharama Madhusudhan; Hosur Ananthashayana Venkatesh; Shivanand Gamanagatti; Pramod Garg; Deep Narayan Srivastava
Journal:  Korean J Radiol       Date:  2016-04-14       Impact factor: 3.500

5.  Clinical and Subclinical Femoral Vascular Complications after Deployment of two Different Vascular Closure Devices or Manual Compression in the Setting of Coronary Intervention.

Authors:  Hakan Yeni; Meissner Axel; Ahmet Örnek; Thomas Butz; Petra Maagh; Gunnar Plehn
Journal:  Int J Med Sci       Date:  2016-02-20       Impact factor: 3.738

6.  Early decision-analytic modeling - a case study on vascular closure devices.

Authors:  Alina Brandes; Moritz F Sinner; Stefan Kääb; Wolf H Rogowski
Journal:  BMC Health Serv Res       Date:  2015-10-27       Impact factor: 2.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.